Tag: Malhar Naik
Three firms act on BioNTech’s USD950m China partner buyout
A&O Shearman, Goodwin, and Conyers are advising BioNTech on its $950M buyout of a Chinese cancer drug partner to rival Merck
A&O Shearman, Goodwin, and Conyers are advising BioNTech on its $950M buyout of a Chinese cancer drug partner to rival Merck
Trademark disputes, regulatory reforms and expansion pressures are forcing businesses to rethink brand protection
Follow us on LinkedIn